Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Jun 17, 2026, 4:00 PM EDT
1.170
+0.010 (0.86%)
After-hours: Jun 17, 2026, 7:45 PM EDT

Bionano Genomics Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Bionano Genomics stock has a consensus rating of "Buy" and an average price target of $5.00. The average 1-year stock price forecast is 331.03% higher than the current stock price, while the lowest is $4.00 (+244.83%) and the highest is $6.00 (+417.24%).

Price Target: $5.00 (+331.03%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$4.00$5.00$5.00$6.00
Change+244.83%+331.03%+331.03%+417.24%

Analyst Ratings

The average analyst rating for Bionano Genomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Nov '25Jan '26Mar '26Apr '26May '26
Strong Buy011111
Buy211111
Hold000000
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$4
BuyMaintains$4+244.83%May 29, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7$6
BuyReiterates$7$6+417.24%Apr 13, 2026

Financial Forecast

Revenue This Year
32.14M
from 28.51M
Increased by 12.73%
Revenue Next Year
43.30M
from 32.14M
Increased by 34.74%
EPS This Year
-2.71
from -4.82
EPS Next Year
-1.11
from -2.71
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
17.98M27.80M36.12M30.78M28.51M32.14M
Revenue Growth
111.47%54.62%29.90%-14.79%-7.37%12.73%
Gross Profit
3.87M5.95M9.57M380.00K13.19M16.07M
Gross Margin
21.54%21.38%26.49%1.23%46.25%50.00%
Operating Income
-75.54M-129.58M-138.69M-87.17M-33.34M-28.79M
Net Income
-72.44M-132.60M-232.49M-112.02M-26.40M-29.19M
EPS
-----4.82-2.71
Free Cash Flow
-38.49M-61.27M-97.26M-2.62M-4.58M201.52M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High32.5M
Avg32.1M
Low31.8M

Revenue Growth

Revenue Growth202620272028
High
13.9%
Avg
12.7%
Low
11.5%

EPS Forecast

EPS202620272028
High-
Avg-2.71
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-